TASTAD CAROLYN M 4
4 · PROCTER & GAMBLE Co · Filed Oct 5, 2021
Insider Transaction Report
Form 4
TASTAD CAROLYN M
CEO - Health Care
Transactions
- Award
Common Stock
[F1]2021-10-01+3,251→ 31,748.363 total - Award
Series A Preferred Stock
[F3][F4]2021-07-19+124.135→ 3,972.428 total(indirect: By Trust)→ Common Stock (124.135 underlying) - Award
Stock Option (Right to Buy)
2021-10-01+62,731→ 62,731 totalExercise: $139.58From: 2024-10-01Exp: 2031-10-01→ Common Stock (62,731 underlying)
Holdings
- 5,828.576(indirect: By Trust)
Common Stock
[F2] - 1,993.282(indirect: By Spouse)
Common Stock
- 662.109(indirect: By Trust)
Common Stock
[F2]
Footnotes (4)
- [F1]Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.
- [F2]Reflects adjustment to PST through September 30, 2021.
- [F3]Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
- [F4]Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
Signature
/s/ Aaron B. Shepherd, attorney-in-fact for Carolyn M. Tastad|2021-10-05